I spoke with Russ Roberts of EconTalk for an hour or so about the Oregon Medicaid study. The conversation took place last Thursday. As you can tell by reading more recent posts on this blog, we’ve learned more since then.
Masthead
Editors in Chief
Austin Frakt
Aaron Carroll
Managing Editor
Adrianna McIntyre
Contributors
Kevin Outterson
Bill Gardner
Nicholas Bagley
Other ContributorsRecent posts
- How Useful Are Temperature Screenings for Covid?
- Veterans Experience Differences Between VHA and Community Providers
- The Health Of The People Should Be The Supreme Law
- What Can Be Learned From Differing Rates of Suicide Among Groups
- At-Home Testing for Covid
- Bias In, Bias Out
- Come work with me (and colleagues you’ve read here)
- Covid Vaccine Facts with the WHO’s Dr. Kate O’Brien
- Nest Protect and the nuclear option
- Religion and COVID: at odds?
Archives
For speaking inquiries
Interested in having Aaron or Austin speak to your group?
For information on Aaron speaking, click here.
For information on Austin speaking, contact the Leigh Bureau.
Aaron’s stuff
Selected appearances:
The Colbert Report
Good Morning America
Sound Medicine (most recent)
The Ed ShowAustin’s stuff
Click here for links to Austin’s peer-reviewed publications and/or related posts.
A podcast on the Medicaid study
05/13/2013
Austin Frakt
item.php
Follow the blog
TIE Books
Amazon.com
Barnes & Noble
Indiebound
iBooks
Google
Kobo
Amazon.com
Barnes & Noble
Books-A-Million
iBooks
IndieBound
Powells
Buy at Amazon.com
Summary
Excerpt: Economic profit
Excerpt: Diminishing marginal utility
Excerpt: Four factors of production
Excerpt: Monopoly marginal revenue
Excerpt: Consumer/producer surplus
Amazon.com
Barnes & Noble
Books-A-Million
Borders
IndieBound
Powells
Borders
Barnes & Noble
IndieBound
Amazon.com
Books-A-Million
Powells
Austin and Aaron are participants in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to amazon.com.Tag cloud
ACA AcademyHealth access accountable care organizations Affordable Care Act announcement blogging cancer comic competitive bidding costs cost shifting COVID-19 employer-sponsored health insurance health care costs Healthcare Triage health insurance health insurance mandates health reform hospital readmissions hospitals individual mandate insurance exchange market power Massachusetts Medicaid Medicare Medicare Advantage mortality nutrition obesity On The Record physicians politics PPACA premiums prescription drugs quality reading list reflex RWJF spending uninsured Upshot vaccines
by Emily on May 13th, 2013 at 12:10
Good audio, though time permitted me to only listen to a bit above 50%.
With regard to limitations of power: There were roughly 15 parameters that created the conclusions drawn that I believe you objected to on the basis of a power calculation. Each parameter had random chance and I think that it is accepted that the research was well done and non biased.
I asked myself:
What is the “power” of study #1? Poor and therefore one might say that the study wasn’t effective in proving the disputed conclusion. If we take another parameter, study #2, and that showed the same result one would think that would help to validate study #1 a bit despite its low power. Take that through the 15 or so studies that are demonstrating the same outcomes and I would believe that the validity would dramatically increase if we accept the validity of the researchers doing appropriate research. I don’t think the researcher’s motives or integrity were questioned.
Depression diagnosis big increase, but did that knowledge improve health? I’ll stay away from that because a lot of conclusions with regard to mental health seem too squishy to me and because of some prior studies I reviewed.
by Brad F on May 13th, 2013 at 18:52
Russ pushed back a bit on the utility of preventive health and for mostly right reasons. He cited Topol from an earlier episode and I think, misunderstood statin linkage with MI rate reduction. He did not make distinction between primary and secondary prevention, NNT, etc. Small quibble, but bad example. Prevention sometimes cost-effective and worth investment– which he skirted over.
He used above to transition into a nod towards a catastrophic coverage only world.. The demarcation he made between Mcaid and others in this regard was minimal. You made the case for financial security and the need for something, in this case Medicaid, because we have no other product. I wish he would have forwarded a more formed solution beyond, “maybe we should give cash.” I wanted something more fully formed given his worldview.
All in all however, a good discussion between two folks with opinions. I wonder if the the same comity would carry over if you both had to hash out a substantive policy solution behind closed doors?
Brad